1) Amrhein V, Greenland S, McShane B:Retire statistical significance. Nature 567(7748):305-307, 2019
2) Azuma K, Komatsu N, Hattori S, Matsueda S, Kawahara A, Sasada T, Itoh K, Hoshino T:Humoral immune responses to EGFR-derived peptides predict progression-free and overall survival of non-small cell lung cancer patients receiving gefitinib. PLoS One 9:e0086667, 2014
3) Blum JL, Jones SE, Buzdar AU, LoRusso PM, Kuter I, Vogel C, Osterwalder B, Burger HU, Brown CS, Griffin T:Multicenter phase Ⅱ study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17:485-493, 1999
4) Cox DR:The regression analysis of binary sequences(with discussion). J R Stat Soc Series B Stat Methodol 20:215-242, 1958
5) Cox DR:Regression models and life-tables(with discussion). J R Stat Soc Series B Methodol 34:187-220, 1972
6) Han P, Wang L:Estimation with missing data:beyond double robustness. Biometrika 100:417-430, 2013
7) Haneuse S, VanderWeele TJ, Arterburn D:Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA 321:602-603, 2019
8) Harrington D, D' Agostino RB Sr, Gatsonis C, Hogan JW, Hunter DJ, Normand ST, Drazen JM, Hamel MB:New guidelines for statistical reporting in the journal. N Engl J Med 381:285-286, 2019
9) Hattori S, Hemni M:Stratified doubly robust estimators for the average causal effect. Biometrics 70:270-277, 2014
10) Hattori S, Zhou XH:Time-dependent summary receiver operating characteristics for meta-analysis of prognostic studies. Stat Med 35:4746-4763, 2016
11) Heagerty PJ, Lumley T, Pepe MS:Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337-344, 2000
12) Rosenbaum PR, Rubin DB:The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55, 1982
13) Sato Y, Gosho M, Nagashima K, Takahashi S, Ware JH, Laird NM:Statistical methods in the Journal-an update. N Engl J Med 376:1086-1087, 2017
14) Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, Shuren J, Temple R, Woodcock J, Yue LQ, Califf RM:Real-world evidence-what is it and what can it tell us? N Engl J Med 375:2293-2297, 2016
15) Tibshirani R:Regression shrinkage and selection via the lasso. J R Stat Soc Series B Methodol 58:276-288, 1996
-values:context, process, and purpose. Am Stat 70:129-133, 2016
17) Weintraub WS, Grau-Sepulveda MV, Weiss JM, O' Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH:Comparative effectiveness of revascularization strategies. N Engl J Med 366:467-476, 2012